A simple supplement improves survival in patients with a new type of heart disease
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 23-Jul-2025 18:10 ET (23-Jul-2025 22:10 GMT/UTC)
A multi-institutional research team led by Osaka University found that tricaprin, a natural supplement, improved long-term survival rates in patients with triglyceride deposit cardiomyovasculopathy, a new type of heart disease characterized by impaired triglyceride breakdown in heart and smooth muscle cells. Tricaprin improved clinical symptoms and long-term survival. Studying the effects of tricaprin on patients of different ethnicities would be an ideal next step to gather more evidence in favor of the drug.
A new book by Professor Luigi Fontana with recipes from Healthy Longevity Chef Marzio Lanzini at the University of Sydney’s Charles Perkins Centre (CPC) has set out a medical science-backed plan for eating more plant-based meals to enhance overall health and longevity.
Can telemedicine and exercise apps improve the health of people with type 2 diabetes and coronary heart disease? A large study led by the Technical University of Munich (TUM) shows that the positive effects are minimal. Study leader Prof. Martin Halle views the results as clear evidence of misplaced priorities in medical care. Direct care from medical professionals remains crucial.
Interventional heart failure (IHF) has rapidly evolved as a critical subspecialty within cardiology at the crossroads of advanced heart failure and interventional cardiology. The increasing complexity of patient care—spanning both pharmacological treatments and an expanding array of device-based therapies—has underscored the urgent need for a standardized approach to training and career development in this field.
That’s the message from experts in a comprehensive review, “Charting the Course for Careers in Interventional Heart Failure: Training, Challenges, Future Directions,” highlighted at Technology and Heart Failure Therapeutics (THT) 2025 in Boston, MA. Co-published in JSCAI, the article highlights and addresses training gaps to advance the specialty, with an eye toward enabling future trainees to drive innovation and improve outcomes for patients with complex heart failure.